Production of Beer with a Genetically Engineered Strain of S. cerevisiae with Modified Beta Glucanase Expression

Yang Shengli1,2,3, Liu Zhongshan2, Chi Shengzhou2, He Sheng2, Meng Qingwei2, Liu Congcong2, Lin Yi2 and He Guoqing1,4
1 Department of Biosystem Engineering and Food Sciences, Zhejiang University, Hangzhou 310029, PR China.
2 Inbev Doubledeer Brewing Group, Wenzhou 325000, PR China.
3 The College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou 310014, PR China. 4 Corresponding author. E-mail: gqhe@zju.edu.cn.

J. Inst. Brew. 115(4), 361–367, 2009  |   VIEW ARTICLE

ABSTRACT
This study used a recombinant Saccharomyces cerevisiae strain, which expressed both β-glucanase enzyme and reduced Proteinase A expression during wort fermentations. The genetic stability and fermentation features of the strain were examined. The recombinant strain’s proteinase A activity was reduced compared to the parent strain; β-glucanase was produced throughout the fermentation. The fermentation with the recombinant S. cerevisiae strain exhibited a larger reduction in β-glucan content than what was observed with the control strain, with β-glucan degradation above 80%. The foam stability period was reduced when the beer produced by the recombinant S. cerevisiae was stored for 3 months. SDS-PAGE analysis of the beer proteins indicated that lipid transfer protein 1 had disappeared. Fermentation studies indicated that based on the parameters examined, this recombinant strain was suitable for industrial beer production.

Key words:
draft beer, foam, β-glucanase, proteinase A, recombinant S. cerevisiae.

Publication no. G-2009-1216-1051  ©2009 The Institute & Guild of Brewing